IL-1 antagonist formulations

Details for Australian Patent Application No. 2005277357 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Dix, Daniel; Chimanlall, Goolcharran; Bowers, Katherine

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005277357

PCT Pub. Number WO2006/023665

Priority 60/602,137 17.08.04 US

Filing date 17 August 2005

Wipo publication date 2 March 2006

Acceptance publication date 4 August 2011

International Classifications

C07K 14/545 (2006.01) Peptides having more than 20 amino acids

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/023665 Priority application(s): WO2006/023665

4 August 2011 Application Accepted

  Published as AU-B-2005277357

1 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005277361-Process for the production of levorphanol and related compounds

2005277356-Tinted contact lenses with gradient ring patterns